Abstracts Terms and Conditions

  • Follow all instructions for completing the submission. Be sure to structure the content into Background, Methods, Results and Conclusions sections.
  • Abstracts are not eligible for consideration if the data have previously been presented or published at a U.S. or international meeting held before the IANS Annual Scientific Meeting.
  • Each presenting author will be asked to comply with the IANS Disclosure Policy. Indication of the relationship, the associated commercial entity and level of support is required for each presenting author. All presenters at IANS Annual Scientific Meeting sessions must display a slide at the beginning of their presentation indicating disclosure information as applicable, or that they have nothing to disclose.
  • The submitter acts on behalf of all co-authors and in submitting an abstract, transfers to IANS the copyright and all other rights in the material comprising the application if the application is accepted. Co-authors reserve the following:
    • All proprietary rights other than copyright, such as patent rights; and
    • The right to use all or part of the application in future works of their own. The meeting organizers, as holder of the copyright on the accepted application, reserve all rights of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats.
  • Abstract submissions will be reviewed by IANS Scientific Committee. All submissions will be selected for a poster presentation and upon author request, will be considered for an oral presentation as well.
  • Abstracts must be submitted by February 28, 2018. Abstract authors will be notified of the status of their submission by March 28, 2018
  • Abstracts received after February 28, 2018 will not be accepted.

International Anal Neoplasia Society

PO Box 1543
Leesburg, Virginia 20177
Powered by Wild Apricot Membership Software